1093751-02-0

Usage

Uses

Used in Organic Synthesis:
6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid is used as a building block for the synthesis of various organic compounds due to its unique molecular structure and reactivity.
Used in Medicinal Chemistry:
6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid is used as a key intermediate in the development of new drugs, as its specific properties and reactivity may contribute to the creation of novel pharmaceutical agents.
Used in Materials Science:
6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid is used as a component in the development of new materials, as its unique structure and properties may offer potential applications in various material systems.
Used in Chemical Processes:
6,6-difluorobicyclo[3.1.0]hexane-3-carboxylic acid is used as a reactant or catalyst in various chemical processes, as its reactivity and properties may enable the development of new and improved methods for chemical synthesis and transformation.

Upstream product

• 58101-60-3 methyl cyclopent-3-ene-1-carboxylate 
• 1093750-99-2 methyl 6,6-difluorobicyclo[3.1.0]hexane-3-carboxylate 

Downstream Products

• 1093751-05-3 cis-3-(4-chlorophenyl)-2-(6,6-difluorobicyclo[3.1.0]hexan-3-yl)-6-methylpyrimidin-4(3H)-one 

Relevant academic research and scientific papers

SUBSTITUTED ARYL PYRIMIDINONES

Substituted aryl pyrimidinones are provided, of the Formula (I) wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.

SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES

Substituted aryl pyrimidinone derivatives are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.

SUBSTITUTED PYRIMIDINONES

Substituted pyrimidinones are provided, of the Formula (I): wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.